MARKET

IMVT

IMVT

Immunovant Inc
NASDAQ
27.49
+0.44
+1.63%
After Hours: 27.36 -0.13 -0.47% 17:13 02/09 EST
OPEN
27.69
PREV CLOSE
27.05
HIGH
27.92
LOW
26.25
VOLUME
1.94M
TURNOVER
--
52 WEEK HIGH
27.92
52 WEEK LOW
12.72
MARKET CAP
5.60B
P/E (TTM)
-9.7152
1D
5D
1M
3M
1Y
5Y
1D
Immunovant Rides Brepocitinib Momentum Into 2026
TipRanks · 3h ago
Immunovant Is Maintained at Buy by Guggenheim
Dow Jones · 13h ago
Guggenheim Maintains Buy on Immunovant, Raises Price Target to $44
Benzinga · 13h ago
Immunovant price target raised to $23 from $22 at Truist
TipRanks · 15h ago
Immunovant (IMVT) Receives a Buy from J.P. Morgan
TipRanks · 15h ago
Immunovant price target raised to $44 from $41 at Guggenheim
TipRanks · 16h ago
Weekly Report: what happened at IMVT last week (0202-0206)?
Weekly Report · 18h ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Immunovant (IMVT) and Roivant Sciences (ROIV)
TipRanks · 1d ago
More
About IMVT
Immunovant, Inc. is a clinical-stage immunology company enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-fragment crystallizable receptor (FcRn) technology, the Company is developing targeted therapies to meet the complex and variable needs of people with autoimmune diseases. Its product pipeline includes its product candidates, IMVT-1402 and batoclimab, both of which are novel, fully human, monoclonal antibodies that target the neonatal FcRn. Subcutaneous injections, IMVT-1402 and batoclimab have been observed to reduce immunoglobulin G (IgG) antibody levels, which has provided evidence supporting the use of an anti-FcRn antibody in disease areas associated with high levels of pathogenic IgG antibodies. The Company is developing batoclimab for myasthenia gravis (MG), thyroid eye disease (TED), chronic inflammatory demyelinating polyneuropathy (CIDP) and Graves’ disease (GD).

Webull offers Immunovant Inc stock information, including NASDAQ: IMVT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMVT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMVT stock methods without spending real money on the virtual paper trading platform.